Osteonic Co (226400.KQ) Stock Price

Osteonic Co Price

CLOSED
4,060.00
​
Market closed

Revenue has compounded at 29.8% per year over the past 11 years to 45.39 B KRW. Earnings per share have grown at 17.7% per year over the last 11 years. Osteonic Co's net margin stands at 16.5%, up from -18.3% several years earlier. Analysts set a median price target of 13,260.00 KRW, implying 226.6% above the current price. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.

Osteonic Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Osteonic Co business model & stock analysis

Osteonic Co Ltd develops and manufactures medical equipment, primarily focusing on cranio maxilla facial (CMF) systems and trauma systems. These products, including plates and screws, are used for fixing and healing broken bones in the cranium, face, jaw, hands, and feet. The company distributes its medical equipment domestically within Seoul and internationally to overseas markets. The firm's products are designed for medical professionals and healthcare facilities requiring orthopedic solutions. Osteonic Co Ltd targets hospitals and clinics that need reliable surgical tools for bone fixation and implant procedures. The company's domestic and international distribution channels support its market reach in both local and global healthcare sectors. Osteonic Co Ltd's revenue streams come from the sale of CMF systems, trauma systems, and related medical equipment. The products are sold to hospitals, clinics, and medical distributors across domestic and overseas markets. The company's focus on specialized orthopedic solutions positions it within the medical equipment manufacturing industry.

Frequently asked questions about Osteonic Co

Analysts currently set an average price target of 13,260.00 KRW for the Osteonic Co stock (median: 13,260.00 KRW), implying +226.6 % versus the latest price. The consensus is based on 5 analyst ratings.

5 analysts currently rate the Osteonic Co stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Osteonic Co to generate revenue of 60.10 B KRW and earnings per share of 877.83 KRW.

Converted at the current exchange rate, the Osteonic Co share trades at 2.73 EUR (4,060.00 KRW).

The expected revenue of Osteonic Co is 60.10 B KRW. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Osteonic Co is 11.37 B KRW. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Osteonic Co is currently 4.63. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Osteonic Co stock.

The price-to-sales ratio (P/S) of Osteonic Co is currently 0.87. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Osteonic Co stock.

The Eulerpool Quality Score for Osteonic Co is 6/10.

The ISIN of Osteonic Co is KR7226400000. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Osteonic Co is 226400.KQ. The ticker symbol is used to trade Osteonic Co shares on the stock exchange.

Fair ValueTerminal
4,222.40 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
463.19 M KRW
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website osteonic.com
Country
South Korea
Currency
KRW
Initial public offering
May 4, 2016
ISIN
KR7226400000
Cusip
Y6S042101
Market capitalization
80.53 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
7.09
P/Ee 2027
—
P/S
P/Se
0.87
EV/EBIT
7.94
P/B Ratio
1.19
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
10.46 %
Last updated Nov 2, 2026, 4:14 AM

Osteonic Co Peer Group

Osteonic Co FIGI

226400:KS · BBG00CTJCPB9226400:KQ · BBG00CTJCPD7

All fundamentals and in-depth analysis of Osteonic Co

Our stock analysis for Osteonic Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Osteonic Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.